EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Development and clinical potential of 18 F-PSiMA for prostate cancer PET imaging

Lexi Gower-Fry iD, Justin J Bailey, Melinda Wuest, Susan Pike, Alexey Kostikov iD, Andreas Dorian, Carmen Wängler iD, Frank Wuest iD, Ralf Schirrmacher

RSC Medicinal Chemistry · 2025 · 16 (8) · 3633-3644

DOI: 10.1039/d5md00275c ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2025. Verfasst von Lexi Gower-Fry und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Alberta Edmonton Alberta Canada schirrma@ualberta.ca. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Alberta Cancer Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Optimized SiFA-PSMA radiotracer, 18 F-PSiMA, offers increased tumor uptake compared to previous lead compound, and negligible bone and salivary gland uptake.

Autor:innen und Institutionen

  • Department of Chemistry, University of Alberta Edmonton Alberta Canada schirrma@ualberta.ca.
  • Department of Oncology, University of Alberta Edmonton Alberta Canada.
  • Department of Neurology and Neurosurgery, McGill University Montreal Quebec Canada.
  • Department of Chemistry, McGill University Montreal Quebec Canada.
  • Biomedical Chemistry, Clinic of Radiology and Nuclear Medicine, Medical Faculty Mannheim, Heidelberg University Germany.
  • Research Campus M2OLIE, Medical Faculty Mannheim, Heidelberg University Germany.

ORCID-Profile: Lexi Gower-Fry, Alexey Kostikov, Carmen Wängler, Frank Wuest

Förderung

  • Natural Sciences and Engineering Research Council of Canada
  • Alberta Cancer Foundation

Zitieren

APA

Gower-Fry, L., Bailey, J. J., Wuest, M., Pike, S., Kostikov, A., Dorian, A., Wängler, C., Wuest, F., & Schirrmacher, R. (2025). Development and clinical potential of 18 F-PSiMA for prostate cancer PET imaging. RSC Medicinal Chemistry, 16(8), 3633-3644. https://doi.org/10.1039/d5md00275c

Vancouver

Gower-Fry L, Bailey JJ, Wuest M, Pike S, Kostikov A, Dorian A, et al. Development and clinical potential of 18 F-PSiMA for prostate cancer PET imaging. RSC Medicinal Chemistry. 2025;16(8):3633-3644. doi:10.1039/d5md00275c

BibTeX
@article{GowerFry2025,
  author = {Gower-Fry, Lexi and Bailey, Justin J and Wuest, Melinda and Pike, Susan and Kostikov, Alexey and Dorian, Andreas and Wängler, Carmen and Wuest, Frank and Schirrmacher, Ralf},
  title = {Development and clinical potential of 18 F-PSiMA for prostate cancer PET imaging},
  journal = {RSC Medicinal Chemistry},
  year = {2025},
  volume = {16},
  number = {8},
  pages = {3633--3644},
  doi = {10.1039/d5md00275c}
}
Kostenlos starten →